Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01348542 · ClinicalTrials.gov registry record · NA

Study of Trazodone & Cognitive Behavioral Therapy to Treat Insomnia

A NA study, sponsored by Milton S. Hershey Medical Center.

Completed
Registry status
NA
Development phase
24
Enrollment target

NCT01348542: Completed NA study, sponsored by Milton S. Hershey Medical Center.

NCT01348542 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01348542, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the effect of a 3 month medication trial of Trazodone versus 3 months of Cognitive Behavioral Therapy (CBT) in patients with chronic insomnia.

Primary Outcome

Polysomnography (8 hours fixed time in bed) will be used to measure sleep duration at baseline and post treatment (3 months)

Interventions

  • DRUG Trazodone
  • BEHAVIORAL Cognitive Behavioral Therapy

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2011-04
Est. Completion 2018-06-01
Phase NA
Milton S. Hershey Medical Center

396 total trials

What the finished NCT01348542 record still lists

NCT01348542 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Trazodone is the first listed.

NCT01348542 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01348542 about?

NCT01348542 is a clinical study titled "Study of Trazodone & Cognitive Behavioral Therapy to Treat Insomnia". The purpose of this study is to evaluate the effect of a 3 month medication trial of Trazodone versus 3 months of Cognitive Behavioral Therapy (CBT) in patients with chronic insomnia.

What is the current status of trial NCT01348542?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2011-04. Estimated completion is 2018-06-01.

What interventions are being tested in trial NCT01348542?

The interventions under investigation include: Trazodone (DRUG), Cognitive Behavioral Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT01348542?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01348542's enrollment target sits among peer trials

24 1736th of 2000 higher than 246 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01348542, the US trial registry maintained by the National Library of Medicine. NCT01348542 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.